Is a complete MCRB research report available?

No complete published report is available for Seres Therapeutics, Inc. (MCRB) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Seres Therapeutics, Inc. (MCRB)

NASDAQ: MCRB · USD

$1.76

-0.04 (-2.2%)· Recorded snapshot

Market cap	17.7M
Revenue (ttm)	1.9M
Net income (ttm)	-22.5M
EPS (ttm)	-$2.41
Shares out	10M
Volume	84,234
Beta	0.31

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.9M
Net income (ttm): -22.5M
EPS (ttm): -$2.41
Market cap: 17.7M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Halten

Metric	Value
Amount currency	USD
CIK code	0001609809
Company name	Seres Therapeutics, Inc.
Country	United States
Country code	US
CUSIP number	81750R201
Earnings date	2026-11-09
Earnings time	bmo
Employees	66
Employees change	-37
Employees growth	-35.92%
Enterprise value	$58.7M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2010
Industry	Biotechnology
IPO date	2015-06-26
Is primary listing	Yes
Is SPAC	No
ISIN number	US81750R2013
Last 10-K release date	2026-03-12
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Last stock split date	2025-04-22
Last stock split type	Reverse
Market cap	$17.7M
Market cap category	Nano-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$1.76
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	MCRB
U.S. state	Massachusetts
Website	https://www.serestherapeutics.com

Metric

Value

Amount currency

USD

CIK code

0001609809

Company name

Seres Therapeutics, Inc.

Country

United States

Country code

CUSIP number

81750R201

Earnings date

2026-11-09

Earnings time

bmo

Employees

Employees change

-37

Employees growth

-35.92%

Enterprise value

$58.7M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2010

Industry

Biotechnology

IPO date

2015-06-26

Is primary listing

Yes

Is SPAC

ISIN number

US81750R2013

Last 10-K release date

2026-03-12

Last earnings date

2026-08-05

Last refreshed

2026-10-28

Last stock split date

2025-04-22

Last stock split type

Reverse

Market cap

$17.7M

Market cap category

Nano-Cap

Next earnings date

2026-11-09

Options

Yes

Price

$1.76

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

MCRB

U.S. state

Massachusetts

Website

https://www.serestherapeutics.com

Metric	Value
Earnings yield	-137.07%
EV/Sales	31.4x
FCF / EV yield	-86.75%
FCF yield	-283.7%
P/B ratio	0.51x
P/S ratio	9.6x
Price / tangible book value	0.52x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-137.07%

EV/Sales

31.4x

FCF / EV yield

-86.75%

FCF yield

-283.7%

P/B ratio

0.51x

P/S ratio

9.6x

Price / tangible book value

0.52x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
Operating margin	-4,154.38%
Pretax margin	-1,192.94%
Profit per employee	$-340,348
Profitable quarters	1
Profitable years	2
Revenue per employee	$28,530
ROA	-39.85%
ROA (5Y)	-30.13%
ROCE	-95.92%
ROE	-66.57%
ROIC	-46.22%
SBC / revenue	487.84%

Metric

Value

Operating margin

-4,154.38%

Pretax margin

-1,192.94%

Profit per employee

$-340,348

Profitable quarters

Profitable years

Revenue per employee

$28,530

ROA

-39.85%

ROA (5Y)

-30.13%

ROCE

-95.92%

ROE

-66.57%

ROIC

-46.22%

SBC / revenue

487.84%

Metric	Value
EPS growth quarters	1
EPS growth years	0
Net income growth quarters	1
Net income growth years	3
Revenue growth (QoQ)	105.59%
Revenue growth 10Y	-10.51%
Revenue growth 3Y	-75.65%
Revenue growth 5Y	-42.5%
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth quarters

Net income growth years

Revenue growth (QoQ)

105.59%

Revenue growth 10Y

-10.51%

Revenue growth 3Y

-75.65%

Revenue growth 5Y

-42.5%

Revenue growth years

Metric	Value
Capital expenditures	$-37,000
Depreciation and amortization	$3.4M
EBIT	$-78.2M
EBITDA	$-74.8M
EPS	$-2.41
FCF per share	$-5.11
Financing cash flow	$14.9M
Free cash flow	$-51.3M
Free cash flow minus SBC	$-60.5M
Gross profit	$-46.1M
Investing cash flow	$187,000
Net cash flow	$-36.2M
Net income	$-22.5M
Operating cash flow minus SBC	$-60.4M
Operating income	$-78.2M
Revenue	$1.9M
Stock-based compensation	$9.2M

Metric

Value

Capital expenditures

$-37,000

Depreciation and amortization

$3.4M

EBIT

$-78.2M

EBITDA

$-74.8M

EPS

$-2.41

FCF per share

$-5.11

Financing cash flow

$14.9M

Free cash flow

$-51.3M

Free cash flow minus SBC

$-60.5M

Gross profit

$-46.1M

Investing cash flow

$187,000

Net cash flow

$-36.2M

Net income

$-22.5M

Operating cash flow minus SBC

$-60.4M

Operating income

$-78.2M

Revenue

$1.9M

Stock-based compensation

$9.2M

Metric	Value
Altman Z-Score	-14.8
Book value per share	$3.51
Debt / equity	1.64
Long-term assets	$59.2M
Long-term liabilities	$47M
Net cash (debt)	$-41.1M
Net cash / market cap	-227.04%
Net debt / equity	1.19
Piotroski F-Score	1
Property, plant and equipment	$57M
Shareholders' equity	$34.5M
Tangible book value	$34.5M
Tangible book value per share	$3.51
Total assets	$101.6M
Total cash	$15.6M
Total debt	$56.6M
Total liabilities	$67.1M
WACC	1.44%

Metric

Value

Altman Z-Score

-14.8

Book value per share

$3.51

Debt / equity

1.64

Long-term assets

$59.2M

Long-term liabilities

$47M

Net cash (debt)

$-41.1M

Net cash / market cap

-227.04%

Net debt / equity

1.19

Piotroski F-Score

Property, plant and equipment

$57M

Shareholders' equity

$34.5M

Tangible book value

$34.5M

Tangible book value per share

$3.51

Total assets

$101.6M

Total cash

$15.6M

Total debt

$56.6M

Total liabilities

$67.1M

WACC

1.44%

Metric	Value
Asset turnover	0.02
Current assets	$42.3M
Current liabilities	$20M
Current ratio	2.11
Net working capital	$18.6M
Quick ratio	2.04
Working capital	$22.3M
Working capital turnover	0.09

Metric

Value

Asset turnover

0.02

Current assets

$42.3M

Current liabilities

$20M

Current ratio

2.11

Net working capital

$18.6M

Quick ratio

2.04

Working capital

$22.3M

Working capital turnover

0.09

Metric	Value
Buyback yield / dilution	-10.8%
Dividend yield	0%
Shareholder yield	-10.8%

Metric

Value

Buyback yield / dilution

-10.8%

Dividend yield

Shareholder yield

-10.8%

Metric	Value
10Y price change	-99.24%
10Y return CAGR	-38.58%
10Y total return	-99.24%
150-day SMA	$5.86
1D price change	-2.22%
1M price change	-49.72%
1M total return	-49.72%
1W price change	-23.38%
1W total return	-23.38%
1Y price change	-89.69%
1Y return CAGR	-89.71%
1Y total return	-89.69%
20-day SMA	$2.46
200-day SMA	$7.25
3M price change	-63.51%
3M total return	-63.51%
3Y price change	-93.59%
3Y return CAGR	-59.96%
3Y total return	-93.59%
50-day SMA	$3.73
50-day SMA vs 200-day SMA	50under200
52-week high	$29.98
52-week high date	2025-11-20
52-week low	$1.68
52-week low date	2026-10-28
5Y price change	-98.57%
5Y return CAGR	-57.24%
5Y total return	-98.57%
6M price change	-75.82%
6M total return	-75.82%
All-time high	$1,040.00
All-time high date	2015-09-09
All-time low	$1.68
All-time low date	2026-10-28
Average true range (ATR)	$0.25
Average volume	83.7K
Beta (1Y)	0.96
Beta (2Y)	1.54
Beta (5Y)	0.31
Change from 52-week high	-94.13%
Change from 52-week low	5.08%
Change from all-time high	-99.83%
Change from all-time low	5.67%
Change from open	2.33%
Day's gap	-4.44%
Dollar volume	$148,252
High price	$1.76
Low price	$1.69
Monthly RSI	32.87
Open price	$1.72
Position in 52-week range	100%
Premarket change	0%
Premarket close	$1.80
Premarket price	$1.80
Previous close	$1.80
Price vs 150-day SMA	-69.82%
Price vs 20-day SMA	-27.9%
Price vs 200-day SMA	-75.58%
Price vs 50-day SMA	-52.51%
Relative volume	1.01
RSI	14.47
Sharpe ratio	-2.07
Sharpe ratio (3Y)	-0.3
Sharpe ratio (5Y)	-0.35
Sortino ratio	-2.5
Sortino ratio (3Y)	-0.37
Sortino ratio (5Y)	-0.45
Volume	84.2K
Weekly RSI	23.7
YTD price change	-88.1%
YTD total return	-88.1%

Metric

Value

10Y price change

-99.24%

10Y return CAGR

-38.58%

10Y total return

-99.24%

150-day SMA

$5.86

1D price change

-2.22%

1M price change

-49.72%

1M total return

-49.72%

1W price change

-23.38%

1W total return

-23.38%

1Y price change

-89.69%

1Y return CAGR

-89.71%

1Y total return

-89.69%

20-day SMA

$2.46

200-day SMA

$7.25

3M price change

-63.51%

3M total return

-63.51%

3Y price change

-93.59%

3Y return CAGR

-59.96%

3Y total return

-93.59%

50-day SMA

$3.73

50-day SMA vs 200-day SMA

50under200

52-week high

$29.98

52-week high date

2025-11-20

52-week low

$1.68

52-week low date

2026-10-28

5Y price change

-98.57%

5Y return CAGR

-57.24%

5Y total return

-98.57%

6M price change

-75.82%

6M total return

-75.82%

All-time high

$1,040.00

All-time high date

2015-09-09

All-time low

$1.68

All-time low date

2026-10-28

Average true range (ATR)

$0.25

Average volume

83.7K

Beta (1Y)

0.96

Beta (2Y)

1.54

Beta (5Y)

0.31

Change from 52-week high

-94.13%

Change from 52-week low

5.08%

Change from all-time high

-99.83%

Change from all-time low

5.67%

Change from open

2.33%

Day's gap

-4.44%

Dollar volume

$148,252

High price

$1.76

Low price

$1.69

Monthly RSI

32.87

Open price

$1.72

Position in 52-week range

100%

Premarket change

Premarket close

$1.80

Premarket price

$1.80

Previous close

$1.80

Price vs 150-day SMA

-69.82%

Price vs 20-day SMA

-27.9%

Price vs 200-day SMA

-75.58%

Price vs 50-day SMA

-52.51%

Relative volume

1.01

RSI

14.47

Sharpe ratio

-2.07

Sharpe ratio (3Y)

-0.3

Sharpe ratio (5Y)

-0.35

Sortino ratio

-2.5

Sortino ratio (3Y)

-0.37

Sortino ratio (5Y)

-0.45

Volume

84.2K

Weekly RSI

23.7

YTD price change

-88.1%

YTD total return

-88.1%

Metric	Value
Float	8.8M
Float percentage	87.94%
Shares change (QoQ)	1.29%
Shares change (YoY)	10.8%
Shares held by insiders	0.55%
Shares held by institutions	9.31%
Shares outstanding	10M
Short % of float	3.56%
Short % of shares	3.13%
Short ratio	5.5 days

Metric

Value

Float

8.8M

Float percentage

87.94%

Shares change (QoQ)

1.29%

Shares change (YoY)

10.8%

Shares held by insiders

0.55%

Shares held by institutions

9.31%

Shares outstanding

10M

Short % of float

3.56%

Short % of shares

3.13%

Short ratio

5.5 days

Seres Therapeutics, Inc. (MCRB)

Price

Financial snapshot

Fair-value bridge

Latest news · MCRB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All MCRB indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on MCRB

Frequently asked questions